Mirae Asset Global Investments
VERA icon

Mirae Asset Global Investments’s Vera Therapeutics VERA Stock Holding History

Mirae Asset Global Investments’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Sell
3,210
-512
-14% -$19.1K ﹤0.01% 1180
2026
Q1 		$150K Buy
3,722
+616
+20% +$26.5K ﹤0.01% 1119
2025
Q4 		$157K Buy
3,106
+639
+26% +$22.7K ﹤0.01% 1193
2025
Q3 		$71.7K Buy
2,467
+3
+0.1% +$69 ﹤0.01% 1285
2025
Q2 		$58.1K Buy
2,464
+331
+16% +$7.44K ﹤0.01% 1234
2025
Q1 		$56.8K Buy
2,133
+23
+1% +$739 ﹤0.01% 1217
2024
Q4 		$87.4K Buy
2,110
+127
+6% +$5.62K ﹤0.01% 1169
2024
Q3 		$86.1K Buy
1,983
+350
+21% +$13.3K ﹤0.01% 1215
2024
Q2 		$56.6K Sell
1,633
-11,397
-87% -$452K ﹤0.01% 1222
2024
Q1 		$340K Sell
13,030
-10,086
-44% -$359K ﹤0.01% 2057
2023
Q4 		$356K Buy
23,116
+2,537
+12% +$32.2K ﹤0.01% 2124
2023
Q3 		$282K Buy
20,579
+4,387
+27% +$75.3K ﹤0.01% 2153
2023
Q2 		$260K Buy
+16,192
New +$146K ﹤0.01% 2247

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Mirae Asset Global Investments's VERA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Vera Therapeutics (VERA) stake by 14% in Q2 2026, selling an estimated $19.1K and leaving 3,210 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1180.

Mirae Asset Global Investments first reported a position in VERA in Q2 2023 and has held it in 13 quarters since. The position peaked at $356K in Q4 2023. 56 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Mirae Asset Global Investments held 3,210 shares of Vera Therapeutics worth $138K as of Q2 2026.
  • Mirae Asset Global Investments sold 512 Vera Therapeutics shares in Q2 2026, an estimated $19.1K.
  • Vera Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1180 holding.
  • Mirae Asset Global Investments first reported a position in Vera Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Mirae Asset Global Investments's Vera Therapeutics position peaked at $356K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.